-
Evaluation of clinical risk stratification to determine benefit from long-term versus short-term androgen deprivation in high-risk localized prostate cancer.
10 Jan 2025 09:18 GMT
… with RT and long-term androgen deprivation therapy (ltADT) for high-risk localized …
-
Androgen Receptor Pathway Inhibitor Therapy for Advanced Prostate Cancer: Secondary Analysis of a Randomized Clinical Trial.
14 Jan 2025 11:24 GMT
… castration-sensitive prostate cancer (CSPC): androgen deprivation therapy (ADT) plus abiraterone acetate and … the Functional Assessment of Cancer Therapy-Prostate (FACT-P) questionnaire, including …
-
Contemporary prostate cancer radiation therapy trials may underestimate the risk of biochemical recurrence.
13 Jan 2025 11:03 GMT
Radiotherapy is often given with androgen deprivation therapy for prostate cancer which … trials performed by the Radiation Therapy Oncology Group (RTOG [now … high-level radiotherapy trials using androgen deprivation therapy was uncommon, possibly rendering …
-
Daily life mobility detects frailty, falls, and functioning in older prostate cancer survivors treated with androgen deprivation therapy.
26 Dec 2024 08:53 GMT
Androgen deprivation therapy (ADT) increases the risk of …
-
Coagulation Factor X Promotes Resistance to Androgen-Deprivation Therapy in Prostate Cancer - Beyond the Abstract
11 Dec 2024 19:36 GMT
… the tumor, enhancing chemotherapy and androgen-deprivation therapy efficacy in mouse models and … Factor (TF). Active FX enhanced androgen-independent tumor growth by activating … progression, and synergized with enzalutamide therapy in multiple mouse models.
…
-
Impact of androgen deprivation therapy in patients with unfavorable intermediate-risk prostate cancer receiving brachytherapy-based dose-escalated radiation therapy.
05 Dec 2024 08:06 GMT
… the benefit of short-term androgen deprivation therapy (ADT) has been established for … dose-escalated external beam radiation therapy (EBRT), the role of ADT …
-
Expert consensus provides unified framework for prostate cancer care in China
21 Jan 2025 00:47 GMT
… -generation hormonal agents combined with androgen deprivation therapy (ADT) for high-volume metastatic …
-
Influences on androgen deprivation therapy prescribing before surgery in high-risk prostate cancer.
26 Nov 2024 11:22 GMT
… inappropriate use of pre-surgical androgen deprivation therapy (ADT), we investigated the determinants …
-
Dynamics in the Prostate Immune Microenvironment Induced by Androgen Deprivation Therapy.
26 Nov 2024 01:27 GMT
… cells in the prostate following androgen deprivation therapy (ADT).
We retrospectively compared prostate …
-
Real-world use of androgen-deprivation therapy intensification for metastatic hormone-sensitive prostate cancer: a systematic review.
15 Nov 2024 12:20 GMT
… -sensitive prostate cancer (mHSPC). While androgen-deprivation therapy (ADT) is a primary treatment … for mHSPC, ADT intensification with androgen receptor pathway inhibitors (ARPIs) and …